Acetaminophen and Codeine Phosphate 300/30 mg tablet recalled over manufacturing violations
- Recall date
- April 15, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- H J Harkins Company Inc dba Pharma Pac recalls Acetaminophen and Codeine Phosphate 300/30 mg tablet, packaged in: a) 10-count bottle (NDC 52959-0003-10), b) 12-count…
- Recall number
- D-1246-2020
- FDA classification
- Class II
- Brand / firm
- H J Harkins Company Inc dba Pharma Pac
- Sold / distributed
- Product was distributed in CA and AZ.
Why it was recalled
cGMP Deviations
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Acetaminophen and Codeine Phosphate 300/30 mg tablet, packaged in: a) 10-count bottle (NDC 52959-0003-10), b) 12-count bottle (NDC 52959-0003-12), c) 14-count bottle (NDC 52959-0003-14), d) 15-count bottle (NDC 52959-0003-15), e) 16-count bottle (NDC 52959-0003-16), f) 20-count bottle (NDC 52959-0003-20), g) 30-count bottle (NDC 52959-0003-30), h) 60-count bottle (NDC 52959-0003-60), Rx Only, Mfg. Aurobindo; Repack: H.J. Harkins Co., Inc., Grover Beach, CA 93433
Get recall alerts
Free email alert whenever H J Harkins Company Inc dba Pharma Pac has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: H J Harkins Company Inc dba Pharma Pac